SELLAS Life Sciences Group, Inc. SLS Research and development expense
Research and development expense at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s research and development expense?
- SELLAS Life Sciences Group, Inc. (SLS) reported research and development expense of $5.13M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s research and development expense changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s research and development expense increased by 60.0% year-over-year, from $3.21M to $5.13M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s research and development expense?
- Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s research and development expense has grown at a 0.6% compound annual growth rate (CAGR), from $15.67M to $16.02M.